PATRICIA KING: Open Payments
NPI 1114956638 · CHESAPEAKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,086 in 53 payments from 13 companies in 2025. Trend: 2023 $1,538 · 2024 $9,028 · 2025 $5,086
Speaker / faculty: $4,000Food & beverage: $1,086
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $4,145 |
| E.R. Squibb & Sons, L.L.C. | 15 | $308 |
| Alkermes, Inc. | 6 | $120 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $98 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $97 |
| Otsuka America Pharmaceutical, Inc. | 3 | $83 |
| Supernus Pharmaceuticals, Inc. | 3 | $69 |
| Teva Pharmaceuticals USA, Inc. | 2 | $36 |
| Vanda Pharmaceuticals Inc. | 1 | $34 |
| Axsome Therapeutics, Inc. | 1 | $29 |
Products named: VRAYLAR, COBENFY, ARISTADA, TRINTELLIX, CAPLYTA, Qelbree, REXULTI, ABILIFY MAINTENA.
Industry payments across VA — which companies pay providers there.
